acelyrin.com - SLRN Company profit before taxes, interest and amortization
Acelyrin, Inc. (SLRN) relies on an extensive network of external laboratories to minimize operational risks. The cash EBITDA trend, with GURU.Markets data illustrated on this chart, shows that the value of is the current metric. The company possesses substantial capital for the development of anti-inflammatory drugs. The innovative VDA platform enables the creation of small proteins that effectively penetrate deep foci of skin pathologies.
ACELYRIN (SLRN) - metric breakdowns and financial figures
- market value and analyst target forecast:
- issuer market value details:
- issuer book value statistics:
- business debt structure and liquidity details:
- earnings and market ratios statistics:
SLRN - Net Income|Expected Net Profit Acelyrin, Inc.|SLRN - Price to Earnings Ratio|Future Price to Earnings Multiple acelyrin.com|SLRN - PEG Multiple|Total Company Value to Operating Income Before Depreciation Ratio ACELYRIN|SLRN - Profit before payment of interest, taxes and amortization|Earnings per share for the last 12 months ACELYRIN|SLRN - Net earnings per share for the last 12 months|Year-over-year earnings per one share growth for the last 12 months acelyrin.com|SLRN - Earnings growth in current year|Consensus forecast of earnings per share growth for next year Acelyrin, Inc.
Summary company analytics:SLRN - ACELYRIN Inc.
For Acelyrin, Inc., whose immunology developments are protected by US and EU healthcare humanitarian status, this indicator serves as a real-time sensor of financial stability between quarterly reports. By analyzing the operating profit before taxes trend on GURU.Markets, an investor tracks the daily cash flow before interest and taxes, which allows for the early recognition of a price correction risk in the event of a systemic decline in business efficiency.
Who Acelyrin, Inc. competes with
Haleon Corp (HLN) - Profit before interest, taxes and amortization|KVUE: Operating profit before deduction of amortization|veronapharma.com - Company profit before taxes, interest and amortization|MENS: Operating profit EBITDA|Ligand Pharmaceuticals Incorporated - Income before deduction of interest, taxes and amortization|AMRX (Amneal Pharmaceuticals Inc) - Operating profit EBITDA|Profit before interest, taxes and amortization Perrigo Corp PRGO|Profit before payment of interest, taxes and amortization Alvotech (ALVO)|LQDA (liquidia.com) - Income before deduction of interest, taxes and amortization|Operating profit EBITDA GLPG (Galapagos)|Operating profit EBITDA ANI Pharmaceuticals Inc ANIP|MannKind Corp. - Operating profit EBITDA|Amphastar Corp (AMPH) - Operating profit before deduction of amortization|PCRX: Operating profit EBITDA|Profit before interest, taxes and amortization ars-pharma.com (SPRY)|Profit before payment of interest, taxes and amortization Theravance Biopharma, Inc.|Profit before payment of interest, taxes and amortization AQST|Operating profit before deduction of amortization SCPH (scPharmaceuticals Inc.)|TECX - Profit before interest, taxes and amortization|Profit before payment of interest, taxes and amortization Tonix Pharmaceuticals TNXP|Income before deduction of interest, taxes and amortization SXTC|Eupraxia Pharma - Operating profit EBITDA|Operating income before deduction of amortization BioHarvest Sciences, Inc. BHST|Invizyne Technologies, Inc. (EXOZ) - Profit before payment of interest, taxes and amortization|Operating profit before amortization ORMP|Operating profit before deduction of amortization ENTX|HYFT: Income before deduction of interest, taxes and amortization|Operating profit EBITDA ABVC|Operating income before deduction of amortization Cumberland Pharmaceuticals Inc|Profit before payment of interest, taxes and amortization Quantum BioPharma Limited QNTM|FGEN: Operating profit before amortization|Telomir Pharmaceuticals - Operating profit EBITDA|Rani Therapeutics (RANI) - Operating profit before deduction of amortization|SNYR (synergychc.com) - Operating profit before deduction of amortization|RLYB - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Lexaria Bioscience Corp|Pulmatrix Corporation (PULM) - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Pheton Holdings Ltd (PTHL)|Profit before payment of interest, taxes and amortization APM (aptorumgroup.com)|Profit before payment of interest, taxes and amortization Lyra Therapeutics LYRA|Income before deduction of interest, taxes and amortization IBO|TNFA - Profit before payment of interest, taxes and amortization|YCBD (cbdMD, Inc.) - Operating profit before amortization|PainReform Ltd. (PRFX) - Profit before payment of interest, taxes and amortization|Profit before deduction of interest, taxes, depreciation and amortization CYTO (Altamira Therapeutics Ltd.)|LIPO (Lipella Pharmaceuticals, Inc.) - Operating profit EBITDA|OPTN: Income before deduction of interest, taxes and amortization|Operating profit EBITDA PIRS|Operating profit EBITDA Procaps Group Corp (PROC)|Profit before payment of interest, taxes and amortization Petros Pharmaceuticals PTPI|Income before deduction of interest, taxes and amortization QLI|TFFP - Profit before payment of interest, taxes and amortization
